RNLX Renalytix Plc Stock Quote

RNLX [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-1.04	Insider Own	-	Shs Outstand	36.12M	Perf Week	-11.96%
Market Cap	524.40M	Forward P/E	-	EPS next Y	-0.62	Insider Trans	-	Shs Float	32.69M	Perf Month	-9.49%
Income	-37.60M	PEG	-	EPS next Q	-0.12	Inst Own	17.90%	Short Float	1.62%	Perf Quarter	-45.80%
Sales	2.00M	P/S	262.20	EPS this Y	-191.50%	Inst Trans	-0.49%	Short Ratio	4.66	Perf Half Y	-56.67%
Book/sh	1.66	P/B	8.16	EPS next Y	-77.10%	ROA	-46.70%	Target Price	28.50	Perf Year	-51.71%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-50.40%	52W Range	12.99 - 35.71	Perf YTD	-14.84%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-44.10%	52W High	-61.47%	Beta	-
Dividend %	-	Quick Ratio	7.80	Sales past 5Y	-	Gross Margin	45.00%	52W Low	5.93%	ATR	1.21
Employees	48	Current Ratio	7.80	Sales Q/Q	-	Oper. Margin	-	RSI (14)	39.44	Volatility	8.62% 7.60%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	-35.30%	Profit Margin	-	Rel Volume	0.96	Prev Close	13.54
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Dec 07 BMO	Payout	-	Avg Volume	113.83K	Price	13.76
Recom	2.50	SMA20	-9.88%	SMA50	-17.10%	SMA200	-43.79%	Volume	80,392	Change	1.62%

Jan-18-22

Initiated

H.C. Wainwright

Buy

$30

Jan-04-22

Initiated

BTIG Research

Buy

$24

Oct-04-21

Initiated

Guggenheim

Buy

$28

Jul-02-21

Initiated

Berenberg

Buy

$38

Aug-11-20

Initiated

Stifel

Buy

Jan-20-22 07:47AM	Renalytix AI PLC Sponsored ADR (RNLX) Surges 10.4%: Is This an Indication of Further Gains? Zacks
Jan-11-22 08:15AM	Positive Study Results Published for KidneyIntelX in Monitoring Patient Response to New Drug Therapy GlobeNewswire +8.09%
Jan-10-22 07:00AM	Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast GlobeNewswire
Jan-07-22 07:00AM	Renalytix Appoints Jean M. Casner as Chief Human Resources Officer GlobeNewswire
Jan-05-22 07:00AM	Renalytix to Present at 40th Annual J.P. Morgan Virtual Healthcare Conference GlobeNewswire
Jan-04-22 11:17AM	Renalytix Ends Down Slightly After ADA Joint Program and Buy Rating Investing.com
07:00AM	American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population GlobeNewswire
Dec-02-21 07:00AM	Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7 GlobeNewswire -5.99%
Nov-20-21 06:09AM	3 Small-Cap Stocks to Buy Now and Hold for the Long Haul Motley Fool
Nov-10-21 07:00AM	Renalytix Convenes Expert Panel at VA Healthcare Summit GlobeNewswire -6.61%
Nov-09-21 07:00AM	St. Josephs Health and Renalytix Partner to Advance Value-Based Kidney Health in New York GlobeNewswire
Oct-25-21 01:53PM	Heres Why Renalytix Plc (RNLX) Landed in Algers Top Detractor List Insider Monkey
Oct-21-21 07:00AM	Renalytix Reports Full Year Fiscal 2021 Results GlobeNewswire +5.59%
Oct-08-21 07:00AM	Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21 GlobeNewswire
Oct-07-21 07:00AM	Renalytix Launching KidneyIntelX in Veterans Health Administration Hospitals GlobeNewswire
06:39AM	3 Growth Stocks Wall Street Thinks Could Rise 50% or More Motley Fool
Sep-29-21 01:14PM	Hedge Funds Are Piling Into Renalytix Plc (RNLX) Insider Monkey
Sep-14-21 07:00AM	Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX Enabled Health Care Model GlobeNewswire -12.45%
Sep-09-21 06:03AM	3 High-Growth Healthcare Stocks to Buy in September Motley Fool -5.53%
Sep-03-21 07:00AM	Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference GlobeNewswire
Aug-30-21 07:00AM	Renalytix Appoints Daniel J. Levangie to its Board of Directors GlobeNewswire +11.81%
06:36AM	3 High-Growth Stocks That Could Soar by 30% or Better According to Wall Street Motley Fool
Aug-26-21 07:00AM	Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX Testing at Primary Care Level GlobeNewswire +7.36%
Aug-03-21 06:16AM	3 High-Growth Healthcare Stocks to Buy in August Motley Fool -5.04%
Jul-28-21 07:00AM	Renalytix Appoints Ann Berman to its Board of Directors GlobeNewswire +7.45%
Jul-26-21 07:00AM	Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference GlobeNewswire
Jul-22-21 07:00AM	Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory GlobeNewswire
Jul-16-21 06:19AM	3 High-Growth Stocks Truly Headed for the Moon Motley Fool
Jul-11-21 08:43AM	3 Top Life Science Stocks to Buy on Sale Right Now Motley Fool
Jun-28-21 07:00AM	KidneyIntelX Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time GlobeNewswire
Jun-15-21 07:00AM	Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021 GlobeNewswire
Jun-10-21 08:00AM	Renalytix to Report Financial Results for Fiscal Third Quarter 2021 and Provide Corporate Update GlobeNewswire
Jun-07-21 07:00AM	Leadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX Deployment GlobeNewswire
Jun-03-21 07:00AM	Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care GlobeNewswire
Jun-02-21 11:34AM	Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order PR Newswire
11:34AM	Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order CNW Group
May-19-21 07:00AM	Atrium Health, Wake Forest Baptist Health, Wake Forest School of Medicine and Renalytix Partner to Advance Kidney Health GlobeNewswire +6.68%
May-04-21 02:20PM	Kantaro's COVID-SeroKlir Antibody Test Named As A Finalist For Fast Company's 2021 World Changing Ideas Awards PR Newswire -5.98%
Apr-22-21 07:00AM	U.S. General Services Administration Grants 10-Year Governmentwide Contract for RenalytixAI KidneyIntelX Testing GlobeNewswire +15.15%
Apr-20-21 07:21AM	Fulgent Genetics' CEO Just Told Investors To Look Out For An Acquisition Motley Fool
07:00AM	KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS) GlobeNewswire
Apr-14-21 07:00AM	RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platform GlobeNewswire
Apr-08-21 07:00AM	Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions GlobeNewswire +5.18%
Apr-05-21 07:00AM	Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure GlobeNewswire
Mar-15-21 07:00AM	Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics GlobeNewswire
Mar-10-21 10:31AM	Kantaro Biosciences Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021 and Ranked First in the Joint Ventures Category PR Newswire
Mar-04-21 01:00PM	Renalytix AI plc Issue of Shares Under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights GlobeNewswire -8.57%
Mar-02-21 07:00AM	RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021 GlobeNewswire
06:30AM	Renalytix AI Plc - ADR to Host Earnings Call ACCESSWIRE
Feb-24-21 08:00AM	The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health GlobeNewswire +7.78%
Feb-23-21 02:00AM	RenalytixAI to announce Financial Results for six and three months ended December 31, 2020 GlobeNewswire -6.35%
Feb-10-21 11:31AM	FDA Adds Kantaro's Semi-Quantitative COVID-19 Antibody Test to Revised Emergency Use Authorization for Convalescent Plasma PR Newswire
Feb-08-21 07:30AM	Kantaro and Atrys Health Partnership Expand Global Footprint of Quantitative COVID-19 Antibody Tests in Europe and South America PR Newswire
Feb-04-21 07:00AM	American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health GlobeNewswire
Jan-13-21 02:00AM	Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics GlobeNewswire +18.77%
Jan-06-21 08:54AM	Renalytix AI (RNLX) Catches Eye: Stock Jumps 7% Zacks
07:30AM	The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping Benzinga
Jan-05-21 06:00AM	Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita GlobeNewswire +6.89%
Jan-04-21 08:05AM	RenalytixAI to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Nov-29-20 11:42AM	Do Hedge Funds Love Renalytix AI plc (RNLX)? Insider Monkey
Nov-25-20 07:30AM	Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies PR Newswire +31.71%
07:00AM	RenalytixAI Reports Financial Results for First Quarter of Fiscal Year 2021 GlobeNewswire
Nov-13-20 02:00AM	RenalytixAI to Participate in the Stifel 2020 Healthcare Conference GlobeNewswire
Nov-06-20 07:00AM	Renalytix AI plc (RenalytixAI or the Company) Change of adviser GlobeNewswire
Nov-02-20 10:30AM	Posting of Annual Report & Accounts and Notice of AGM GlobeNewswire
Oct-28-20 07:30AM	EKF and Kantaro Partner to Market Quantitative COVID-19 Antibody Testing in the UK and Europe PR Newswire
Oct-27-20 03:00AM	Renalytix AI plc (RenalytixAI or the Company) Full Year Report GlobeNewswire
Oct-26-20 07:30AM	CE Mark Approval Granted to Kantaro COVID-SeroKlir and COVID-SeroIndex Quantitative Antibody Test Kits PR Newswire +6.19%
Sep-22-20 07:00AM	RenalytixAI Receives California Commercial Laboratory Certification GlobeNewswire
Sep-18-20 07:00AM	RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System GlobeNewswire
Aug-26-20 07:00AM	RenalytixAI Files Submission Seeking U.S. FDA Clearance of KidneyIntelX GlobeNewswire
Aug-21-20 03:00AM	RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease GlobeNewswire
Aug-03-20 08:00AM	KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients GlobeNewswire +7.33%
Jul-27-20 08:00AM	RenalytixAI Announces Over Allotment Option Exercise Raises an Additional US$10.9M GlobeNewswire +6.17%
Jul-21-20 03:57PM	RenalytixAI Announces Closing of Global Offering and Resulting Total Voting Rights GlobeNewswire
Jul-16-20 11:38PM	RenalytixAI Announces Pricing of Global Offering and Approval to List on the Nasdaq Global Market GlobeNewswire

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience